ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

VHC vs TMO // EV/EBITDA & P/E VALUATION

VirnetX Holding Corp (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: VHC 1 — TMO 7
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VHC VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC VHC TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 9.30% -44.30 TMO /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 30.4x — TIE /valuation <GO>
Free Cash Flow Yield — 2.40% — TIE /fcf-yield <GO>
Operating Margin -60.00% 17.40% -77.40 TMO /operating-margins <GO>
Net Profit Margin -60.00% 15.10% -75.10 TMO /net-margins <GO>
Revenue Growth (YoY) 180.00% 3.90% +176.10 VHC /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.24% -0.24 TMO /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 4.50 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 8/9 -5.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 37.2 62.9 -25.70 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.94 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 36.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $43.9M $262.22B -$262.17B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR VHC REV TMO REV VHC GROSS % TMO GROSS % VHC FCF TMO FCF
FY 2025 $162.0K $44.56B — — -$15.7M $6.29B
FY 2024 $5.0K $42.88B — — -$15.3M $7.27B
FY 2023 $7.0K $42.86B — — -$24.8M $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VHC // BETA —
TMO // BETA 0.94